Skip to content

Does Framing and Humor Improve the Effectiveness of Messages About COVID-19 Vaccine

A Randomized Controlled Trial Testing the Efficacy of Humor and Framing in Messaging to Correct Misperceptions About COVID-19 Vaccines

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05085613
Enrollment
100
Registered
2021-10-20
Start date
2021-10-31
Completion date
2022-03-31
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Beliefs

Brief summary

This study seeks to assess the efficacy of educational messages to correct misperceptions. People hold a number of misperceptions that are relevant to public health, including misperceptions regarding COVID vaccines. Some people incorrectly think the COVID vaccines authorized by FDA are not safe or effective. These misperceptions can reduce adherence to public health recommendations and result in continued spread of COVID. This study will test if humor and different types of framing increase the efficacy of messages to correct misperceptions about FDA's authorized coronavirus vaccine safety and effectiveness. The frames tested will include: framing the vaccine as a way to boost economic recovery and framing the vaccine as a way to increase freedom to choose how to behave. The addition of humor will also be tested. Message efficacy will be measured via improved accuracy of beliefs after being exposed to the message. In other words, participants will be asked how safe and effective FDA authorized COVID vaccines are before seeing a message, then they will see a message about why the COVID vaccines are safe and effective, and then they will again be asked how safe and effective they think the vaccines are. This study will also assess the accuracy of inferential beliefs. This will be accomplished by asking participants questions about other vaccines that either are or are not authorized by FDA. If participants have understood the messages and updated their mental models of how FDA evaluates vaccines, they should be able to infer if other vaccines are safe and effective based on their FDA authorization status. Hypotheses H1: Participants who are exposed to A.) a message with humor, B.) a message with an economic recovery fame, or C.) a message with a freedom frame will be more likely to increase their agreement with the statement that the FDA will only authorize coronavirus vaccines that are safe and effective after message exposure than participants exposed to the control condition. H2: Participants who are exposed to A.) a message with humor, B.) a message with an economic recovery fame, or C.) a message with a freedom frame will agree more strongly with the statement that the FDA approved flu vaccine is safe and effective after message exposure than participants exposed to the control condition. H3. Participants who are exposed to A.) a message with humor, B.) a message with an economic recovery fame, or C.) a message with a freedom frame will agree more strongly with the statement that the ResVax vaccine, which was not approved by the FDA for the treatment of RSV, is a safe and effective after message exposure than participants exposed to the control condition. H4. Participants who are exposed to A.) a message with humor, B.) a message with an economic recovery fame, or C.) a message with a freedom frame will be more likely to increase behavioral intentions to get an FDA authorized COVID vaccine after message exposure than participants exposed to the control condition.

Interventions

BEHAVIORALCorrective message framing and humor

The main content of the messages will be the same. Experimental conditions (arms 2-4) will additionally include consequent framing as a result of getting vaccinated (e.g. economic recovery for arm 2 and freedom for arm 3) and humor for arm 4. Participants will be randomized to view one of the four messages.

Sponsors

Johns Hopkins Bloomberg School of Public Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Intervention model description

Model Description: Participants will be randomized to view one of four messages. The control message explains why people are hesitant to accept the FDA authorized COVID vaccines are safe and effective and how they are evaluated. Arm 2 additionally includes consequent framing regarding economic recovery (e.g. If everyone gets vaccinated, we can keep schools, stores, and other businesses open so more Americans can keep working and supporting their families. With a picture of an open for business sign), arm 3 includes consequent framing regarding freedom to behave as one chooses (e.g. Everyone getting vaccinated is the key to freedom! A vaccine can give us the freedom to hang out with friends, shop, and worship together again safely. With a picture of an American flag), and arm 4 includes humor (e.g. Unfortunately, everyone getting vaccinated means leaving the house again.).

Eligibility

Sex/Gender
ALL
Age
21 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Are 21 years of age or older. * Have not participated in the cognitive interview. * Have not yet received a COVID vaccine. * Are registered with MTurk in the United States. * Have completed \>= 5,000 HIITs within the MTurk system * Have a HIIT approval rating of \>= 97% * Rate their agreement with the following statement as less than or equal to 50 out of 100: To what extent do you agree with the following: The FDA only authorizes COVID vaccines that are safe and effective.

Exclusion criteria

* Are younger than 21 years of age * Participated in the cognitive interviews * Have already received a COVID vaccine. * Are not registered with MTurk in the US * Have completed \< 5,000 HIITS * Have a HIIT approval rating of \<97% * Rate their agreement with the following statement as greater than 50 out of 100: To what extent do you agree with the following: The FDA only authorizes COVID vaccines that are safe and effective.

Design outcomes

Primary

MeasureTime frameDescription
Change in Accuracy of the Belief That FDA Authorized COVID-19 Vaccines Are Safe and EffectiveBaseline and up to 5 minutes after receiving the corrective messageAssessed by change in response to the question To what extent do you agree or disagree with the following statement: The FDA has only authorized COVID vaccines that are safe and effective; with response options on a continuous scale from 0 I do not agree at all to 100, I completely agree.
Accuracy of Inferential Belief That the FDA Authorized Flu Vaccine is Safe and EffectiveUp to 5 minutes after receiving the corrective messageAssessed by response to the question To what extent do you agree with the following: The FDA authorized flu vaccine is safe and effective.; with response options on a continuous scale from 0 I do not agree at all to 100, I completely agree.
Accuracy of Inferential Belief That RexVax is Safe and EffectiveUp to 5 minutes after receiving the corrective messageAssessed by response to the question, The FDA recommended more testing of ResVax and did NOT authorize the vaccine because it did not prevent enough RSV infections. To what extent do you agree with the following: ResVax is safe and effective; with response options on a continuous scale from 0 I do not agree at all to 100, I completely agree.
Change in Intention to Get a COVID-19 VaccineBaseline and up to 5 minutes after receiving the corrective messageAssessed by change in response to the statement: I plan on getting an FDA authorized coronavirus vaccine; with response options on a continuous scale from 0 I do not agree at all to 100, I completely agree.

Countries

United States

Participant flow

Participants by arm

ArmCount
Vaccine Corrective Control
A message that explains why people are hesitant to accept the FDA authorized COVID vaccines are safe and effective and how the vaccines are evaluated as safe and effective by FDA. Corrective message framing and humor: The main content of the messages will be the same. Experimental conditions (arms 2-4) will additionally include consequent framing as a result of getting vaccinated (e.g. economic recovery for arm 2 and freedom for arm 3) and humor for arm 4. Participants will be randomized to view one of the four messages.
27
Vaccine Corrective With Economic Recovery Framing
The content of the control message with the addition of the text, If everyone gets vaccinated, we can keep schools, stores, and other businesses open so more Americans can keep working and supporting their families. The message will also include a picture of an open for business sign. Corrective message framing and humor: The main content of the messages will be the same. Experimental conditions (arms 2-4) will additionally include consequent framing as a result of getting vaccinated (e.g. economic recovery for arm 2 and freedom for arm 3) and humor for arm 4. Participants will be randomized to view one of the four messages.
27
Vaccine Corrective With Freedom Framing
The content of the control message with the addition of the text, Everyone getting vaccinated is the key to freedom! A vaccine can give us the freedom to hang out with friends, shop, and worship together again safely. The message will also include a picture of an American flag. Corrective message framing and humor: The main content of the messages will be the same. Experimental conditions (arms 2-4) will additionally include consequent framing as a result of getting vaccinated (e.g. economic recovery for arm 2 and freedom for arm 3) and humor for arm 4. Participants will be randomized to view one of the four messages.
24
Vaccine Corrective With Humor
The content of the control message with the addition of the text, Unfortunately, everyone getting vaccinated means leaving the house again. The message will include a meme of a cat being pulled/rescued from a window with text boxes labeling the cat as People at home working in sweatpants and the rescuer as COVID Vaccines. Corrective message framing and humor: The main content of the messages will be the same. Experimental conditions (arms 2-4) will additionally include consequent framing as a result of getting vaccinated (e.g. economic recovery for arm 2 and freedom for arm 3) and humor for arm 4. Participants will be randomized to view one of the four messages.
22
Total100

Baseline characteristics

CharacteristicVaccine Corrective ControlVaccine Corrective With Economic Recovery FramingVaccine Corrective With Freedom FramingVaccine Corrective With HumorTotal
Age, Continuous39 years
STANDARD_DEVIATION 9.9
41.4 years
STANDARD_DEVIATION 11.9
43.3 years
STANDARD_DEVIATION 9.2
40.8 years
STANDARD_DEVIATION 9.7
41.1 years
STANDARD_DEVIATION 10.3
Political affiliation
Conservative
11 Participants18 Participants16 Participants13 Participants58 Participants
Political affiliation
Liberal
3 Participants4 Participants6 Participants3 Participants16 Participants
Political affiliation
Moderate
13 Participants5 Participants2 Participants6 Participants26 Participants
Race/Ethnicity, Customized
Race/ethnicity
Non-Hispanic White
19 Participants24 Participants20 Participants16 Participants79 Participants
Race/Ethnicity, Customized
Race/ethnicity
Racial/ethnic minority
8 Participants3 Participants4 Participants6 Participants21 Participants
Sex: Female, Male
Female
8 Participants15 Participants10 Participants9 Participants42 Participants
Sex: Female, Male
Male
19 Participants12 Participants14 Participants13 Participants58 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 270 / 270 / 240 / 22
other
Total, other adverse events
0 / 270 / 270 / 240 / 22
serious
Total, serious adverse events
0 / 270 / 270 / 240 / 22

Outcome results

Primary

Accuracy of Inferential Belief That RexVax is Safe and Effective

Assessed by response to the question, The FDA recommended more testing of ResVax and did NOT authorize the vaccine because it did not prevent enough RSV infections. To what extent do you agree with the following: ResVax is safe and effective; with response options on a continuous scale from 0 I do not agree at all to 100, I completely agree.

Time frame: Up to 5 minutes after receiving the corrective message

ArmMeasureValue (MEAN)Dispersion
Vaccine Corrective ControlAccuracy of Inferential Belief That RexVax is Safe and Effective14.923077 units on a scaleStandard Deviation 20.853629
Vaccine Corrective With Economic Recovery FramingAccuracy of Inferential Belief That RexVax is Safe and Effective14.24 units on a scaleStandard Deviation 23.502269
Vaccine Corrective With Freedom FramingAccuracy of Inferential Belief That RexVax is Safe and Effective12.47619 units on a scaleStandard Deviation 17.28473
Vaccine Corrective With HumorAccuracy of Inferential Belief That RexVax is Safe and Effective23.863636 units on a scaleStandard Deviation 28.782097
Comparison: Note that analyses are underpowered due to administrative issues with funding that halted recruitment early.p-value: 0.99495% CI: [-16.98852, 14.07451]ANCOVA
Comparison: Note that analyses are underpowered due to administrative issues with funding that halted recruitment early.p-value: 0.99895% CI: [-17.34491, 15.14973]ANCOVA
Comparison: Note that analyses are underpowered due to administrative issues with funding that halted recruitment early.p-value: 0.44795% CI: [-7.110771, 24.96315]ANCOVA
Primary

Accuracy of Inferential Belief That the FDA Authorized Flu Vaccine is Safe and Effective

Assessed by response to the question To what extent do you agree with the following: The FDA authorized flu vaccine is safe and effective.; with response options on a continuous scale from 0 I do not agree at all to 100, I completely agree.

Time frame: Up to 5 minutes after receiving the corrective message

ArmMeasureValue (MEAN)Dispersion
Vaccine Corrective ControlAccuracy of Inferential Belief That the FDA Authorized Flu Vaccine is Safe and Effective37.074074 score on a 0-100 scaleStandard Deviation 33.546668
Vaccine Corrective With Economic Recovery FramingAccuracy of Inferential Belief That the FDA Authorized Flu Vaccine is Safe and Effective44.666667 score on a 0-100 scaleStandard Deviation 31.619128
Vaccine Corrective With Freedom FramingAccuracy of Inferential Belief That the FDA Authorized Flu Vaccine is Safe and Effective49.583333 score on a 0-100 scaleStandard Deviation 35.808569
Vaccine Corrective With HumorAccuracy of Inferential Belief That the FDA Authorized Flu Vaccine is Safe and Effective50.954545 score on a 0-100 scaleStandard Deviation 35.18993
Comparison: Note that analyses are underpowered due to administrative issues with funding that halted recruitment early.p-value: 0.81395% CI: [-14.39448, 28.39899]ANCOVA
Comparison: Note that analyses are underpowered due to administrative issues with funding that halted recruitment early.p-value: 0.26895% CI: [-6.938055, 37.18234]ANCOVA
Comparison: Note that analyses are underpowered due to administrative issues with funding that halted recruitment early.p-value: 0.3395% CI: [-8.218891, 37.0253]ANCOVA
Primary

Change in Accuracy of the Belief That FDA Authorized COVID-19 Vaccines Are Safe and Effective

Assessed by change in response to the question To what extent do you agree or disagree with the following statement: The FDA has only authorized COVID vaccines that are safe and effective; with response options on a continuous scale from 0 I do not agree at all to 100, I completely agree.

Time frame: Baseline and up to 5 minutes after receiving the corrective message

ArmMeasureValue (MEAN)Dispersion
Vaccine Corrective ControlChange in Accuracy of the Belief That FDA Authorized COVID-19 Vaccines Are Safe and Effective20.1 score on a 0-100 scaleStandard Deviation 23.8
Vaccine Corrective With Economic Recovery FramingChange in Accuracy of the Belief That FDA Authorized COVID-19 Vaccines Are Safe and Effective22.8 score on a 0-100 scaleStandard Deviation 24
Vaccine Corrective With Freedom FramingChange in Accuracy of the Belief That FDA Authorized COVID-19 Vaccines Are Safe and Effective24.2 score on a 0-100 scaleStandard Deviation 26.9
Vaccine Corrective With HumorChange in Accuracy of the Belief That FDA Authorized COVID-19 Vaccines Are Safe and Effective22.7 score on a 0-100 scaleStandard Deviation 24.1
Comparison: Note that analyses are underpowered due to administrative issues with funding that halted recruitment early.p-value: 0.99895% CI: [-9.463627, 10.71961]ANCOVA
Comparison: Note that analyses are underpowered due to administrative issues with funding that halted recruitment early.p-value: 0.72595% CI: [-6.416608, 14.505]ANCOVA
Comparison: Note that analyses are underpowered due to administrative issues with funding that halted recruitment early.p-value: 0.9895% CI: [-12.25295, 9.179834]ANCOVA
Primary

Change in Intention to Get a COVID-19 Vaccine

Assessed by change in response to the statement: I plan on getting an FDA authorized coronavirus vaccine; with response options on a continuous scale from 0 I do not agree at all to 100, I completely agree.

Time frame: Baseline and up to 5 minutes after receiving the corrective message

ArmMeasureValue (MEAN)Dispersion
Vaccine Corrective ControlChange in Intention to Get a COVID-19 Vaccine15.925926 score on a 0-100 scaleStandard Deviation 24.935187
Vaccine Corrective With Economic Recovery FramingChange in Intention to Get a COVID-19 Vaccine9.4814815 score on a 0-100 scaleStandard Deviation 16.032108
Vaccine Corrective With Freedom FramingChange in Intention to Get a COVID-19 Vaccine9.625 score on a 0-100 scaleStandard Deviation 21.906546
Vaccine Corrective With HumorChange in Intention to Get a COVID-19 Vaccine12.863636 score on a 0-100 scaleStandard Deviation 20.2797
Comparison: Note that analyses are underpowered due to administrative issues with funding that halted recruitment early.p-value: 0.11395% CI: [-8.985328, 0.6761041]ANCOVA
Comparison: Note that analyses are underpowered due to administrative issues with funding that halted recruitment early.p-value: 0.47395% CI: [-7.6609, 2.289114]ANCOVA
Comparison: Note that analyses are underpowered due to administrative issues with funding that halted recruitment early.p-value: 0.00895% CI: [-11.58151, -1.358358]ANCOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026